CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $93.1 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of $1.59 per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.74 per share.
The biopharmaceutical company posted revenue of $30.2 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $21.8 million.
Agios Pharmaceuticals shares have increased 15% since the beginning of the year. The stock has dropped 37% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO